MicroRNA miR-371a-3p in serum of patients with germ cell tumours: Evaluations for establishing a serum biomarker

Andrology

Volumn 3, Issue 1, 2015, Pages 78-84

  Spiekermann, M ^a   Belge, G ^a   Winter, N ^a   Ikogho, R ^b   Balks, T ^b   Bullerdiek, J ^a,c   Dieckmann, K P ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b ALBERTINEN KRANKENHAUS   (Germany)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

CIS testis; Epigenetics; MicroRNA 371; Serum biomarker; Testicular neoplasms

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 371A 3P; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN371 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; MALE; MALIGNANT PLEURA EFFUSION; ORCHIECTOMY; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINAL PLASMA; TESTICULAR INTRAEPITHELIAL NEOPLASIA; TESTIS CANCER; BLOOD; CANCER STAGING; CASE CONTROL STUDY; EVALUATION STUDY; GENETICS; NEOPLASMS, GERM CELL AND EMBRYONAL; PATHOLOGY; PREDICTIVE VALUE; TESTICULAR NEOPLASMS; TIME; TREATMENT OUTCOME; UPREGULATION;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; HUMANS; MALE; MICRORNAS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; TESTICULAR NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84923259069     PISSN: 20472919     EISSN: 20472927     Source Type: Journal    
DOI: 10.1111/j.2047-2927.2014.00269.x     Document Type: Article

References (28)

1. Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, Kroh EM, Bendoraite A, Mitchell PS & Nelson AM. (2008) MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cell 26, 2496-2505.
2. Bartel DP. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
3. Belge G, Dieckmann KP, Spiekermann M, Balks T & Bullerdiek J. (2012) Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors? Eur Urol 61, 1068-1069.
4. Bezan A, Gerger A & Pichler M. (2014) MicroRNAs in Testicular Cancer: implications for Pathogenesis, Diagnosis, Prognosis and Therapy. Anticancer Res 34, 2709-2713.
5. Bullerdiek J & Flor I. (2012) Exosome-delivered microRNAs of "chromosome 19 microRNA cluster" as immunomodulators in pregnancy and tumorigenesis. Mol Cytogenet 5, 27-30.
6. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T & Visakorpi T. (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59, 671-681.
7. Dieckmann KP & Skakkebaek NE. (1999) Carcinoma in situ of the testis: a review of biological and clinical features. Int J Cancer 83, 815-822.
8. Dieckmann KP, Spiekermann M, Balks T, Flor I, Löning T, Bullerdiek J & Belge G. (2012) MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 107, 1754-1760.
9. Esquela-Kerscher A & Slack FJ. (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269.
10. Farazi TA, Spitzer JI, Morozov P & Tuschl T. (2011) miRNAs in human cancer. J Pathol 223, 102-115.
11. Gillis A, Stopp H, Hermus R, Oosterhuis J, Sun Y, Chen C, Guenther S, Sherlock J, Veltma I & Baeten J. (2007) High throughput microRNAome analysis in human germ cell tumors. J Pathol 213, 319-328.
12. Gillis AJ, Rijlaarsdam MA, Eini R, Dorssers LC, Biermann K, Murray MJ, Nicholson JC, Coleman N, Dieckmann KP, Belge G, Bullerdiek J, Xu T, Bernard N & Looijenga LH. (2013) Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle. Mol Oncol 7, 1083-1092.
13. Laurent LC, Chen J, Ulitsky I, Mueller FJ, Lu C, Shamir R, Fan JB & Loring JF. (2008) Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells 26, 1506-1516.
14. Livak KJ & Schmittgen TD. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
15. Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Müller SC & Ellinger J. (2011) Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 7, 1265. e9.
16. McIver SC, Loveland KL, Roman SD, Nixon B, Kitazawa R & McLaughlin EA. (2013) The chemokine CXCL12 and its receptor CXCR4 are implicated in human seminoma metastasis. Andrology 1, 517-529.
17. Murray MJ & Coleman N. (2012) Testicular cancer: a new generation of biomarkers for malignant germ cell tumours. Nat Rev Urol 9, 298-300.
18. Murray MJ, Halsall DJ, Hook CE, Williams DM, Nicholson JC & Coleman N. (2011) Identification of microRNAs from the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 135, 119-125.
19. Novotny GW, Belling KC, Bramsen JB, Nielsen JE, Bork-Jensen J, Almstrup K, Sonne SB, Kjems J, Rajpert-De Meyts E & Leffers H. (2012) MicroRNA Expression Profiling of Carcinoma In Situ (CIS) Cells of the Testis. Endocr Relat Cancer 19, 365-379.
20. Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ, Coleman N & Children's Leukaemia Group. (2010) Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70, 2911-2923.
21. Reis LO, Pereira TC, Lopes-Cendes I & Ferreira U. (2010) MicroRNAs: a new paradigm on molecular urological oncology. Urology 76, 521-527.
22. Ren J, Jin P, Wang E, Marincola FM & Stroncek DF. (2009) MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med 7, 20-36.
23. Ruf CG, Dinger D, Port M, Schmelz HU, Wagner W, Matthies C, Müller-Myhsok B, Meineke V & Abend M. (2014) Small RNAs in the peripheral blood discriminate metastasized from non-metastasized seminoma. Mol Cancer 13, 47.
24. Sanders I, Holdenrieder S, Walgenbach-Brünagel G, von Ruecker A, Kristiansen G, Müller SC & Ellinger J. (2012) Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer andrenal cell carcinoma. Int J Urology 19, 1017-1025.
25. Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC & Ellinger J. (2012) Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol 32, 353-358.
26. Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC & Ellinger J. (2014) Circulating serum microRNA (miR-367-3p, miR-371a-3p, miR-372-3p, miR-373-3p) as biomarkers for patients with testicular germ cell cancers. J Urol. doi: 10.1016/j.juro.2014.07.010. [Epub ahead of print, Jul 18]
27. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KW, Lee MJ, Galas DJ & Wang K. (2010) The MicroRNA Spectrum in 12 Body Fluids. Clin Chem 56, 1733-1741.
28. Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC & Ellinger J. (2011) MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS ONE 6, e25787.